Several inflammatory factors, such as TNF‐α, IL‐1β and IL‐6, have been proved to enable steatosis and liver damage, thus promoting the occurrence and progression of NASH.84, 85. This evidence concerns the gene IL6 and metabolic dysfunction-associated steatohepatitis.